日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Response to PCSK9 Inhibition Based on LDL Receptor Function in Familial Hypercholesterolemia: A Nonrandomized Clinical Trial

基于LDL受体功能的PCSK9抑制剂治疗家族性高胆固醇血症的疗效:一项非随机临床试验

Raal, Frederick J; Fourie, Nyda; Scott, Russell; Blom, Dirk J; Basson, Matthys M De Vries; Kayikcioglu, Meral; Roth, Mendel; Vest, Jeffrey; Kallend, David; Stein, Evan A

Homozygous Familial Hypercholesterolemia Is a Life-Limiting Condition: Medical Life-Trajectories in the Post-2010 Era

纯合子家族性高胆固醇血症是一种危及生命的疾病:2010 年后的医疗生命轨迹

Mulder, Janneke W C M; Reijman, M Doortje; Kusters, D Meeike; Boersma, Eric; Alnouri, Fahad; Blom, Dirk J; Catapano, Alberico L; Cuchel, Marina; Dann, Eldad J; Freiberger, Tomas; Groselj, Urh; Harada-Shiba, Mariko; Hovingh, G Kees; Iatan, Iulia; Ibarretxe, Daiana; Kayikcioglu, Meral; Kim, Ngoc-Thanh; Klingel, Reinhard; Raal, Frederick J; Reeskamp, Laurens F; Sadiq, Fouzia; Schonck, Willemijn A M; Tromp, Tycho R; Truong, Thanh-Huong; Wiegman, Albert; Roeters van Lennep, Jeanine E

Implementation strategies for improving the care of familial hypercholesterolaemia from the International Atherosclerosis Society: next steps in implementation science and practice

国际动脉粥样硬化学会提出的改善家族性高胆固醇血症护理的实施策略:实施科学与实践的下一步

Sarkies, Mitchell N; Watts, Gerald F; Gidding, Samuel S; Santos, Raul D; Hegele, Robert A; Raal, Frederick J; Sturm, Amy C; Al-Rasadi, Khalid; Blom, Dirk J; Daccord, Magdalena; de Ferranti, Sarah D; Folco, Emanuela; Libby, Peter; Mata, Pedro; Nawawi, Hapizah M; Ramaswami, Uma; Ray, Kausik K; Yamashita, Shizuya; Pang, Jing; Thompson, Gilbert R; Jones, Laney K

Life Course Approach for Managing Familial Hypercholesterolemia

以生命历程方法管理家族性高胆固醇血症

Gidding, Samuel S; Blom, Dirk J; McCrindle, Brian; Ramaswami, Uma; Santos, Raul D; Watts, Gerald F; Wiegman, Albert

Homozygous Familial Hypercholesterolemia Treatment: New Developments

纯合子家族性高胆固醇血症的治疗:最新进展

Blom, Dirk J; Marais, A David; Raal, Frederick J

NOS3 rs3918188C>A is associated with susceptibility to resistant hypertension while CES1 genetic variation was not associated with resistant hypertension among South Africans.

NOS3 rs3918188C>A 与南非人患难治性高血压的易感性相关,而 CES1 基因变异与南非人的难治性高血压无关

Katsukunya Jonathan N, Naicker Revina, Soko Nyarai D, Blom Dirk, Sinxadi Phumla, Chimusa Emile R, Rayner Brian, Jones Erika, Dandara Collet

Impact of statins as immune-modulatory agents on inflammatory markers in adults with chronic diseases: A systematic review and meta-analysis

他汀类药物作为免疫调节剂对慢性病成人炎症标志物的影响:系统评价和荟萃分析

Sabeel, Solima; Motaung, Bongani; Nguyen, Kim A; Ozturk, Mumin; Mukasa, Sandra L; Wolmarans, Karen; Blom, Dirk J; Sliwa, Karen; Nepolo, Emmanuel; Günther, Gunar; Wilkinson, Robert J; Schacht, Claudia; Kengne, Andre Pascal; Thienemann, Friedrich; Guler, Reto

Dysbetalipoproteinaemia in genetically predisposed Ghanaians

遗传易感加纳人的β脂蛋白异常血症

Ateko, Richmond Owusu; Marais, Adrian David; Blom, Dirk Jacobus; Adadey, Samuel Mawuli; Thomford, Nicholas Ekow; Blackhurst, Diane Mary

Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia

纯合子家族性高胆固醇血症的诊断、治疗和心血管结局中的性别差异

Mulder, Janneke W C M; Tromp, Tycho R; Al-Khnifsawi, Mutaz; Blom, Dirk J; Chlebus, Krysztof; Cuchel, Marina; D'Erasmo, Laura; Gallo, Antonio; Hovingh, G Kees; Kim, Ngoc Thanh; Long, Jiang; Raal, Frederick J; Schonck, Willemijn A M; Soran, Handrean; Truong, Thanh-Huong; Boersma, Eric; Roeters van Lennep, Jeanine E

Genetic Variation in ABCB1, ADRB1, CYP3A4, CYP3A5, NEDD4L and NR3C2 Confers Differential Susceptibility to Resistant Hypertension among South Africans

ABCB1、ADRB1、CYP3A4、CYP3A5、NEDD4L 和 NR3C2 基因的遗传变异导致南非人对难治性高血压的易感性存在差异

Katsukunya, Jonathan N; Jones, Erika; Soko, Nyarai D; Blom, Dirk; Sinxadi, Phumla; Rayner, Brian; Dandara, Collet